Company

Intellia Therapeutics, Inc.

NTLA · CIK 0001652130

SEC FORM 4

$36,205.00

Sale of 2,785 shares at $13.00 per share.

Reporting Person LEONARD JOHN M · Officer Title President and CEO · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001193125-26-363567 · filed 2026-08-24 · View filing →

SEC FORM 4

$250,614.00

Sale of 19,890 shares at $12.60 per share.

Reporting Person LEONARD JOHN M · Officer Title President and CEO · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001193125-26-363567 · filed 2026-08-24 · View filing →